Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase.

Fragment-based lead discovery has been successfully applied to the aspartyl protease enzyme beta-secretase (BACE-1). Fragment hits that contained an aminopyridine motif binding to the two catalytic aspartic acid residues in the active site of the enzyme were the chemical starting points. Structure-based design approaches have led to identification of low micromolar lead compounds that retain these interactions and additionally occupy adjacent hydrophobic pockets of the active site. These leads form two subseries, for which compounds 4 (IC50 = 25 microM) and 6c (IC50 = 24 microM) are representative. In the latter series, further optimization has led to 8a (IC50 = 690 nM).

[1]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[2]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[3]  Sahil Patel,et al.  Apo and Inhibitor Complex Structures of BACE (β-secretase) , 2004 .

[4]  C. Oefner,et al.  Substituted piperidines--highly potent renin inhibitors due to induced fit adaptation of the active site. , 1999, Bioorganic & medicinal chemistry letters.

[5]  F. Winkler,et al.  Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases? , 1999, Chemistry & biology.

[6]  I. Khanna,et al.  Facile, Regioselective Syntheses of N-Alkylated 2,3-Diaminopyridines and Imidazo[4,5-b]pyridines , 1995 .

[7]  A. Hopkins,et al.  Ligand efficiency: a useful metric for lead selection. , 2004, Drug discovery today.

[8]  M Katharine Holloway,et al.  Identification of a small molecule nonpeptide active site beta-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases. , 2004, Journal of medicinal chemistry.

[9]  Lin Hong,et al.  Crystal Structure of Memapsin 2 (β-Secretase) in Complex with an Inhibitor OM00-3† , 2002 .

[10]  M. Kansy,et al.  Piperidine-renin inhibitors compounds with improved physicochemical properties. , 1999, Bioorganic & medicinal chemistry letters.

[11]  Stephen Hanessian,et al.  Structure-based design, synthesis, and memapsin 2 (BACE) inhibitory activity of carbocyclic and heterocyclic peptidomimetics. , 2005 .

[12]  John B. Thomas,et al.  Axon routing across the midline controlled by the Drosophila Derailed receptor , 1999, Nature.

[13]  M. Redinbo.  Promiscuity: what protects us, perplexes us. , 2004, Drug discovery today.

[14]  R. Barbour,et al.  Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.

[15]  Michael J. Hartshorn,et al.  AstexViewerTM †: a visualisation aid for structure-based drug design , 2002, J. Comput. Aided Mol. Des..

[16]  Alison R. Gregro,et al.  Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1). , 2004, Journal of medicinal chemistry.

[17]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[18]  David G. Tew,et al.  Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase , 1999, Molecular and Cellular Neuroscience.

[19]  P. Rakic,et al.  Contact-dependent inhibition of cortical neurite growth mediated by notch signaling. , 1999, Science.

[20]  Jean-Louis Kraus,et al.  BACE-1 inhibitory activities of new substituted phenyl-piperazine coupled to various heterocycles: chromene, coumarin and quinoline. , 2006, Bioorganic & medicinal chemistry letters.

[21]  Arun K. Ghosh,et al.  Structure-Based Design: Potent Inhibitors of Human Brain Memapsin 2 (β-Secretase) , 2001 .

[22]  L Hong,et al.  Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. , 2000, Science.

[23]  R. Heinrikson,et al.  Human β-Secretase (BACE) and BACE Inhibitors , 2003 .

[24]  P. Saftig,et al.  Control of Peripheral Nerve Myelination by the ß-Secretase BACE1 , 2006, Science.

[25]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[26]  Paul Watson,et al.  A web-based platform for virtual screening. , 2003, Journal of molecular graphics & modelling.